When mice were monitored up to 14 days post-infection, CXCR2 LOF mice also exhibited significantly reduced overall survival compared to control mice, and this reduction appeared to improve with CXCR4 antagonist treatment (Figure 4D). This evidence concerns the gene CXCR4 and infection.